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ABSTRACT
The Pro‐Inflammatory Contributions of Receptors for Advanced Glycation
End‐Products (RAGE) in Alveolar Macrophages Following
Cigarette Smoke Exposure
Adam B. Robinson
Department of Physiology and Developmental Biology, BYU
Master of Science
Receptors for advanced glycation end‐products (RAGE) are multi‐ligand cell surface
receptors of the immunoglobin family expressed by epithelium and macrophages. RAGE
expression increases following ligand binding and when diverse cells are exposed to a variety of
insults including cigarette smoke extract (CSE). The current research sought to characterize the
pro‐inflammatory contributions of RAGE expressed by alveolar macrophages (AMs) following
CSE exposure. Acute exposure of mice to CSE via nasal instillation revealed diminished
bronchoalveolar lavage (BAL) cellularity and fewer AMs in RAGE null mice compared to
controls. Primary AMs were obtained from BAL, exposed to CSE in vitro, and RNA, DNA, and
protein were analyzed. CSE significantly increased RAGE expression by wild type AMs.
Employing ELISAs, wild type AMs exposed to CSE had increased levels of active Ras, a small
GTPase that perpetuates pro‐inflammatory signaling. Conversely, RAGE null AMs had less Ras
activation compared to wild type AMs after exposure to CSE. In RAGE null AMs, assessment of
p38 MAPK and NF‐B, important intracellular signaling intermediates induced during an
inflammatory response, revealed CSE‐induced inflammation occurs at least in part via RAGE
signaling. For example, activated p38 was diminished in RAGE null AMs compared to controls
and assessment of phosphorylated NF‐B in CSE exposed RAGE null AMs suggest lessened
nuclear translocation of NF‐B compared to wild type AMs exposed to CSE. Importantly,
quantitative RT‐PCR revealed that mRNA expression of pro‐inflammatory cytokines including
TNF‐ and IL‐1 were detectably decreased and analysis of secreted proteins by ELISA
displayed diminished IL‐1 in RAGE null AMs exposed to CSE compared to CSE‐exposed wild
type AMs. These results reveal that primary AMs orchestrate CSE‐induced inflammation, at
least in part, via RAGE‐mediated mechanisms.
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CHAPTER 1:

INTRODUCTION

During the sixteenth and seventeenth centuries, tobacco was recommended to treat
many medical complaints including airway diseases until epinephrine was introduced in the
early twentieth century (46). Decades later, increasing evidence revealed the harmful effects of
tobacco smoke, specifically in asthmatics (7). Today, tobacco use is the second major cause of
death in the world and by 2030, if trends continue, smoking is estimated to kill more than nine
million people annually (50). The number one cause for death related to smoking is myocardial
infarction; however smoking significantly increases the risk of death from peripheral vascular
disease, cerebrovascular disease, chronic obstructive pulmonary disease, and a host of
malignancies including those that affect the lung, breast, pancreas, and prostate (6, 21, 44).
Tobacco smoking is the main risk factor for the hastened degeneration of lung function
observed in patients diagnosed with Chronic Obstructive Pulmonary Disease (COPD) (33).
COPD is currently the fourth leading cause of death in the world and is projected to increase in
the next decade. The indirect yearly cost of COPD has been estimated to be upwards of twenty
three billion dollars (10).

COPD is characterized by airflow limitations stemming from

inflammation of the airways, respiratory parenchyma, and pulmonary vasculature (31).
Interestingly, even with smoking cessation, leukocyte‐mediated inflammation does not resolve
and patients continue to progress (18). Persistent inflammation, a hallmark of COPD, also leads
to adverse airway remodeling, culminating in the destruction of lung parenchyma associated
with emphysema.

Eliciting abnormal enlargement of the distal airspaces, emphysema

mechanistically involves inflammation‐mediated disruption of elastic fibers and tissue loss that
culminate in diminished alveolar septa (16, 20). Despite the pervasiveness of COPD, its precise
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pathophysiological mechanisms are not well known. Furthermore, a clearer understanding of
causative mechanisms may provide avenues for valuable research into lessening the
debilitating effects of disease progression
Cigarette smoke is postulated to consist of over 4700 components (51) and chemical
assessment reveals that it contains high levels of reactive oxygen species that activate nuclear
factor kappa B (NF‐B). Cigarette smoke contains approximately 1017 oxidants per puff (32),
several carcinogens including nitrosamines, polycyclic aromatic hydrocarbons, and aromatic
amines (13), and thousands of other chemicals that have cytotoxic, mutagenic, carcinogenic, or
antigenic properties (26). These compounds and cytokines stimulate and interact with nearly
all airway cells, causing a variety of signaling cascades to occur. Such cascades are mediated by
the sequential activation of intermediate signaling proteins including mitogen activating protein
kinases (MAPK) such as ERK1/2, JNK, and p38, and transcription factors such as early growth
response gene 1 (EGR‐1) and NF‐B, furthering the expression of additional cytokines and
inflammatory mediators (28, 36, 41). Specifically, p38 kinases, a family of MAPKs detected in
epithelial cells and macrophages, have been found to be involved in the inflammatory response
following cigarette smoke exposure (8).
Inflammation involves interrelated processes that center on the activation of the
immune system in order to defend against infection and/or repair tissue damage. The effects
of even basic inflammatory responses become amplified and problematic in the lung due to the
critical nature of its role in gas exchange. A significant outcome of inflammation in the lung
includes the influx and accumulation of phagocytic and reactive immune cells at the site of
injury, including monocytes and macrophages (11).

Macrophages are not only key to
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eradicating the body of pathogens, debris, apoptotic cells, and some tumor cells, they are also
one of the most active secretory cells in the body (24, 25). At a site of acute inflammation,
monocytes aggregate, often stimulated to differentiate into their progeny macrophages,
leading to increased inflammatory activation (52). Activated macrophages simultaneously
produce pro‐inflammatory cytokines that amplify the immune response by up‐regulating
adhesion molecules required for neutrophil and monocyte chemotaxis. These same cytokines
also help to induce monocyte differentiation into macrophages. Primary cytokines that have
been found to be responsible for acute inflammation stemming from tobacco smoke exposure
include tumor necrosis factor  (TNF), interleukin‐1IL‐1, and interleukin‐6 (IL‐6) (47). In
addition to pro‐inflammatory cytokines, macrophages also secrete collagenases and elastases
that destroy connective tissue contributing to emphysema (29). Interestingly, the current
hypothesis describing mechanisms leading to COPD suggest cigarette smoke causes airway
inflammation by activating immune cells including alveolar macrophages, which release pro‐
inflammatory mediators such as those previously described (18, 42).
Cytokines are small protein molecules involved in intercellular signaling, some of which
can be found up‐regulated most often during an immune response. Cytokines that perpetuate
the immune response are termed “pro‐inflammatory” cytokines such as IL‐1, TNF‐, and
others. Release of pro‐inflammatory cytokines appears from nearly any nucleated cell and are
known to locally stimulate leukocyte proliferation, cytotoxicity, release of proteolytic enzymes,
and synthesis of prostaglandins and initiate a cascade of “secondary” cytokine synthesis and
secretion (5). However, endothelium, epithelium, and macrophages are the most potent
producers of IL‐1, TNF‐, and IL‐6 (5). IL‐1 signals through the IL‐1 receptor, which is shown
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to lead to downstream activation of NF‐B, and leads to effects similar to TNF‐ excluding
inducing apoptosis (9, 12). TNF‐, one of the first cytokines to be discovered, was initially
described as the principal mediator of endotoxin related inflammation and is now known to be
a key player in the development of septic shock (1). TNF‐ binds TNF receptors signaling
activation of JNK/MAPK such as p38 MAPK, increasing translocation NF‐B, and stimulating
production of several pro‐inflammatory cytokines, growth factors, and reactive oxygen species
(25). TNF signaling cascades lead to possible cell‐induced apoptosis, leukocyte migration,
activation of phagocytic immune cells, and exacerbation of tissue injury (25, 49).
RAGE, the receptor for advanced glycation end‐products, is a member of the
immunoglobin superfamily of cell surface receptors found in various cell types including smooth
muscle cells, fibroblasts, macrophages, and epithelium (40). The receptor contains a V‐region‐
like domain essential for ligand binding and two C‐region like domains, a single‐pass
hydrophobic transmembrane domain and a short, 43 amino acid, highly charged cytoplasmic
domain essential for intracellular signaling (4). RAGE is found to exist in several isoforms,
namely full length RAGE, dominant negative RAGE (dn‐RAGE), and soluble RAGE (sRAGE). The
full length RAGE receptor contains all domains; however, splicing variants may give rise to the
two other mentioned isoforms. Dn‐RAGE is a membrane anchored splice variant of RAGE
capable of ligand binding but lacking the intracellular domain necessary for signal transduction.
RAGE has also been shown to exist in a soluble secreted form sRAGE. The sRAGE isoform yields
the same V and C‐regions of the full length‐RAGE but lacks both the hydrophobic
transmembrane and the intracellular domains (4). The altered variants of RAGE are thought to
bind and mop up ligands without the consequences of activating signal transduction and
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initiating gene transcription and have been proposed as possible therapeutic targets in the
reduction of RAGE‐mediated inflammatory responses in various tissues.
RAGE is a dynamic receptor capable of binding ligands of various types, being able to
distinguish tertiary structures (30).

RAGE is most abundant in the lung (3) with sparse

expression in alveolar type II (ATII) cells and abundant expression on basolateral membranes of
alveolar type I (ATI) differentiated cells (43). Recently, RAGE has been shown by our lab to
mediate inflammatory signals following smoke exposure in lung epithelial cells (38, 39). Initially
characterized and named for its ability to bind to non‐enzymatically glycoxidized
macromolecules, advanced glycation end‐products (AGEs), RAGE also binds a myriad of other
molecules including pro‐inflammatory cytokine‐like mediators of the S100/calgranulin family
(S100A12 and S100B), amyloid ‐fibrils, high mobility group box 1 (HMGB1), Mac‐1 (4, 43), and
specific DNA and RNA structures (45).
Because RAGE binds a handful of ligands it is thus linked to several signaling pathways.
These include PI3/Akt (48), RhoGTPases (19), Jak/STAT (22), and Src family kinases (34). Of
notable interest are two pathways stimulated by RAGE activation that are in response to either
damage‐associated molecular patterns (DAMPs) (NF‐B pathways) (2) or tobacco smoke‐
induced pulmonary inflammation (Ras pathway) (40). Key DAMP molecules are those of the
S100/calgranulin family and HMGB1, both of which bind to RAGE among other receptors
including toll‐like receptor 4 (TLR4) (17, 39). These molecules, normally secreted following
apoptotic or necrotic events, can serve as trophic factors in low concentrations or enhance the
inflammatory/cell death response in high concentrations.

Downstream gene products

produced through RAGE signaling are thought to include NF‐B, Cox‐2, IL‐1, and TNF‐ (2).
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Because the RAGE gene contains NF‐B and SP‐1 promoter binding sites (27) and is regulated
by Egr‐1 in cases of tobacco smoke‐related disease (37), a possible auto‐inflammatory loop may
be triggered giving suggestion to RAGE involvement in chronic disease states.
Previous work in our lab demonstrated that RAGE, S100A12, and HMGB1 were up
regulated in several immortalized cell lines including rat (R3/1) and human (A549) alveolar
epithelial cells and macrophages (RAW264.7) following exposure to cigarette smoke extract
(CSE). Additional published studies also reported that Ras was induced in R3/1 cells after
exposure to CSE, resulting in up‐regulation of NF‐B, leading to increased secretion of pro‐
inflammatory cytokines such as TNF‐ and IL‐1 (36, 40). Ras is an intracellular signaling
molecule that alternates between an active guanosine triphosphate bound and inactive
guanosine diphosphate bound state (14, 35). Furthermore, Ras is a key regulator of many
features of normal cell growth and malignant transformation (15). Ras has also been associated
with development, cellular proliferation, and differentiation, as a result of the signaling through
MAPK kinase (35). When macrophage RAGE is stimulated by HMGB1, three MAP kinases, p38
MAPK, p44/42 MAPK, and SAPK/JNK were phosphorylated (23). Whether Ras mediates the
activities of these signaling intermediates is untested. Furthermore, the direct role of Ras
signaling following pulmonary macrophage stimulation by CSE and the subsequent release of
cytokines requires further investigation. This and other research that considers acute lung
exposure to cigarette smoke may yield important data related to alveolar macrophage
activation. Furthermore, RAGE may be further implicated in the debilitating expression of pro‐
inflammatory cytokines and their functions in respiratory disease.
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The following chapter (ch.2) is a copy of the published manuscript that includes the
research completed during my tenure at BYU studying alveolar macrophages and their role in
cigarette smoke‐induced inflammation. The manuscript was published in the American Journal
of Physiology, Lung Cellular and Molecular Physiology.

Chapter 2
Robinson AB, Johnson KD, Bennion BG, Reynolds PR. RAGE signaling by alveolar macrophages
influences tobacco smoke‐induced inflammation. Am J Physiol Lung Cell Mol Physiol. 2012 Apr
13. [Epub ahead of print]
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Abstract
Receptors for advanced glycation end‐products (RAGE) are multi‐ligand cell surface
receptors of the immunoglobin family expressed by epithelium and macrophages and
expression increases following exposure to cigarette smoke extract (CSE). The current study
sought to characterize the pro‐inflammatory contributions of RAGE expressed by alveolar
macrophages (AMs) following CSE exposure.

Acute exposure of mice to CSE via nasal

instillation revealed diminished bronchoalveolar lavage (BAL) cellularity and fewer AMs in RAGE
knock out (KO) mice compared to controls. Primary AMs were obtained from BAL, exposed to
CSE in vitro, and analyzed. CSE significantly increased RAGE expression by wild type AMs.
Employing ELISAs, wild type AMs exposed to CSE had increased levels of active Ras, a small
GTPase that perpetuates pro‐inflammatory signaling. Conversely, RAGE KO AMs had less Ras
activation compared to wild type AMs after exposure to CSE. In RAGE KO AMs, assessment of
p38 MAPK and NF‐B, important intracellular signaling intermediates induced during an
inflammatory response, revealed CSE‐induced inflammation may occur in part via RAGE
signaling.

Lastly, quantitative RT‐PCR revealed that the expression of pro‐inflammatory

cytokines including TNF‐ and IL‐1were detectably decreased in RAGE KO AMs exposed to
CSE compared to CSE‐exposed wild type AMs.

These results reveal that primary AMs

orchestrate CSE‐induced inflammation, at least in part, via RAGE‐mediated mechanisms.

Key words: RAGE, lung, macrophages, tobacco
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Introduction
If trends continue, tobacco use in 2030 will kill an estimated nine million people
annually (56). Smoking is the main risk factor for degeneration of lung function observed in
patients with chronic obstructive pulmonary disease (COPD). COPD is currently the fourth
leading cause of death worldwide and in 2010 the economic burden associated to COPD was
projected to be $49.9 billion, which includes $29.5 billion in direct costs (8).

COPD is

characterized by airflow limitations stemming from inflammation of the airways, respiratory
parenchyma, and pulmonary vasculature (32). Interestingly, even with smoking cessation,
leukocyte‐mediated inflammation does not resolve and patients continue to progress (18).
Persistent inflammation also leads to adverse airway remodeling, culminating in the destruction
of lung parenchyma observed in emphysema. Eliciting abnormal enlargement of the distal
airspaces, emphysema mechanistically involves inflammation‐mediated disruption of elastic
fibers and tissue loss that culminate in diminished alveolar septa (13, 21).

Despite the

pervasiveness of COPD, its precise pathophysiological mechanisms are not well known.
Furthermore, a clearer understanding of causative mechanisms may provide avenues for
research into lessening the debilitating effects of disease progression.
Inflammation involves interrelated processes that center on the activation of the
immune system in order to defend against infection and/or repair of damaged tissue. The
effects of even basic inflammatory responses become amplified and problematic in the lung
due to the critical nature of its role in gas exchange. A significant outcome of inflammation in
the lung includes the influx and accumulation of phagocytic and reactive immune cells at the
site of injury (16). Activated macrophages produce pro‐inflammatory cytokines that amplify the
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immune response via up‐regulation of adhesion molecules required for leukocyte chemotaxis.
Simultaneously, cytokines also help to induce monocyte differentiation into additional
macrophages (15). Among others, the primary cytokines responsible for acute inflammation
stemming from tobacco smoke exposure include tumor necrosis factor‐ (TNF‐) and
Interleukin‐1 (IL‐1) (7, 48). In addition to pro‐inflammatory cytokines, macrophages also
secrete collagenases and elastases that destroy connective tissue in the lung.
The receptor for advanced glycation end‐products, or RAGE, is a member of the
immunoglobin superfamily of cell surface receptors found in various cell types including smooth
muscle cells, fibroblasts, macrophages, and epithelium (40). RAGE is most abundant in the lung
(2) with sparse expression by alveolar type (AT) II cells and abundant expression on membranes
of differentiated ATI cells (44). Although RAGE was first described as a progression factor in
cellular responses induced by advanced glycation end‐products (AGEs) that accumulate in
hyperglycemia and oxidant stress, studies have also indicated that RAGE binds a myriad of
other

molecules

(28)

including

pro‐inflammatory

cytokine‐like

mediators

of

the

S100/calgranulin family (S100A12 and S100B), amyloid ‐fibrils, high mobility group box 1
(HMGB1), Mac‐1 (3, 44) and specific DNA and RNA structures (45).
RAGE expression increases as its ligands accumulate and RAGE‐ligand interactions may
contribute to pathological processes including diabetic complications, neurodegenerative
disorders, atherosclerosis, and inflammation.

We have recently demonstrated that RAGE

influences CSE‐induced inflammation mediated by pulmonary epithelial cells. Specifically CSE
induces pulmonary epithelium to increase the expression of RAGE, its ligands, Egr‐1 (a
transcription factor abundantly expressed in the lungs COPD patients), pro‐inflammatory
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signaling intermediates, and various cytokines (37‐39). The possibility that AMs cooperate with
pulmonary epithelium in CSE‐induced inflammation via up‐regulation of RAGE and its signaling
pathway has not yet been assessed.
As an intracellular signaling molecule that regulates the fate of target cells, Ras oscillates
between active guanosine triphosphate (GTP)‐bound and inactive guanosine diphosphate
(GDP)‐ bound conformations (11). Ras signaling has been associated with development, cellular
proliferation, and differentiation, as a result of signaling through Raf/MAP kinase, PI3K,
JNK/p38, and Rho pathways (36). Furthermore, Ras is a key regulator of many features of
normal cell growth and malignant transformation, as a result of the signaling through mitogen‐
activated protein kinases (MAPKs) (12). Published work by our lab provides evidence indicating
that the role of Ras in inflammation appears to be downstream of RAGE in pulmonary epithelial
cells. However, the role of Ras and other intermediate signaling molecules in AMs stimulated
by CSE requires further investigation.
In the present study, we tested the hypothesis that AMs exposed to CSE induce RAGE
and that signaling involving Ras, p38 MAPK, and pro‐inflammatory cytokine secretion occurs via
RAGE‐mediated mechanisms. Although RAGE KO AMs are purported to be indistinguishable
from AMs from wild type strains of mice (53), we demonstrate that RAGE KO AMs exposed to
CSE experience reduced Ras and p38 MAPK activation, less NF‐B translocation, and diminished
production of TNF‐ and IL‐1 when compared to CSE exposed wild type AMs. Collectively,
these data offer new insights into the potential mechanisms whereby RAGE expressed by AMs
participates in inflammation following tobacco smoke exposure.

Further research may
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demonstrate that RAGE, and its specific downstream effectors, are potential targets in the
treatment or prevention of tobacco smoke related pulmonary complications.
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Materials and Methods
Mice
Wild type C57Bl/6 mice were obtained from Jackson Laboratories (Bar Harbor, ME).
RAGE KO mice that lack RAGE were generated in a C57BL/6 background (50). In line with The
Guide for the Care and Use of Laboratory Animals and approved IACUC protocols at Brigham
Young University, mice had free access to food and water and were housed in a dedicated
animal facility that controlled for light, temperature, and humidity. Bronchoalveolar lavage
fluid (BALF) was obtained from RAGE KO and C57Bl/6 control mice as outlined below.
Additional mice were nasally instilled with either sterile PBS or 10% CSE (37) as outlined
previously (35). 24 hours after nasal instillation, lungs (n = 6 mice per group) were inflation
fixed for immunohistochemistry as already described (38) or used to determine total cell
quantity and differential cell counts in BALF as already outlined (35).
Bronchoalveolar lavage fluid (BALF) and cell culture
To obtain BALF, mice were sedated and then exsanguinated to ensure euthanasia as
outlined previously (40). BALF was specifically harvested through the instillation and recovery
of seven 1 ml boluses of PBS attached to a catheter for a total of 7 ml. Each 7 ml sample of
BALF was centrifuged at 1000 RPM for 10 minutes. The cell pellet was resuspended in warm
DMEM and equal concentrations of approximately 50,000 cells were plated and allowed to
adhere overnight before exposure to CSE (37) or fresh DMEM. Cells were exposed to 10% CSE
for 30 minutes to 4 hours depending on the experiment. Following exposure to either CSE or
fresh media, cells were washed with two changes of PBS before total RNA or protein was
isolated.
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Immunocytochemistry and quantitative RT‐PCR
Cells obtained from BALF were washed and fixed with 4% paraformaldehyde and
stained for Mac‐3 (1:50, BD Biosciences, San Jose, CA), an antibody that recognizes the 110 kDa
Mac‐3 protein expressed by mononuclear phagocytes, and a goat anti‐rat secondary antibody
(Santa Cruz Biotechnology, Santa Cruz, CA) as outlined previously (39). Sections of lung tissue
(5 m each) were similarly immunostained with Mac‐3 in order to qualitatively assess relative
AM quantity. Total RNA was isolated from cells using the Qiagen RNeasy Plus Micro kit
(QIAGEN, Valencia, CA,) in accordance with the provided instructions and reverse transcription
of RNA was performed using the Invitrogen Superscript III First‐Strand Synthesis System (Life
Technologies, Grand Island, NY) in order to obtain cDNA for PCR. The following primers were
synthesized and HPLC purified by Invitrogen Life Technologies: RAGE (For‐ACT ACC GAG TCC
GAG TCT ACC and Rev‐GTA GCT TCC CTC AGA CAC ACA), TNF‐ (For‐TGC CTA TGT CTC AGC CTC
TTC and Rev‐GAG GCC ATT TGG GAA CTT CT), IL‐1 (For‐TGT AAT GAA AGA CGG CAC ACC and
Rev‐TCT TCT TTG GGT ATT GCT TGG), and GAPDH (For‐TAT GTC GTG GAG TCT ACT GGT and Rev‐
GAG TTG TCA TAT TTC TCG TGG). cDNA amplification and data analysis were performed using
Bio Rad iQ SYBR Green Supermix (Bio‐Rad Laboratories, Hercules, CA) and a Bio Rad Single Color
Real Time PCR detection system (Bio‐Rad Laboratories, Hercules, CA). Primers were used at a
concentration of 75 nM each in 25‐µl reactions. Cycle parameters were as follows: 3 min at
95°C, and 40 cycles composed of 1 min at 95°C, 15 sec at 55°C and 15 s at 72°C. Control wells
lacking template or RT were included to identify primer‐dimer products and to exclude possible
contaminants.
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Ras activation ELISA
Ras Activation ELISA Kits (Millipore, Temecula, CA) were used to assess active and
inactive Ras (39). Cell lysates were quantified by BCA assay then screened for Ras in 20 g
aliquots of total cell lysates obtained by homogenizing cells in RIPA buffer with inhibitors (Santa
Cruz Biotechnology, Santa Cruz, CA). In vitro experiments were repeated at least three times,
each in triplicate.
p38 MAPK and NF‐B Fast Activated Cell‐Based ELISA (FACE)
Total and active p38 and NF‐B levels were assessed through the use of colorimetric
high‐throughput FACE assays available from Active Motif (Carlsbad, CA). Briefly, freshly isolated
AMs from RAGE KO and control mice were plated overnight as outlined and a time course of
10% CSE exposure that ranged from 30 minutes to 4 hours was conducted. Cells were then
screened with antibodies specific to total and active phosphorylated proteins as outlined in the
manufacturer’s instructions.
Statistics
Mean values  S.D. from three experimental replicates were assessed by one and two‐
way analysis of variance (ANOVA). When ANOVA indicated significant differences, student t
tests were used with Bonferroni correction for multiple comparisons.
representative and those with p values <0.05 were considered significant.

Results are
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Results
AMs induce RAGE expression following CSE exposure
Wild type and RAGE KO mice were exposed to an acute bolus of PBS or CSE and BALF
was assessed. Total cell quantity in BALF was significantly increased in wild type mice following
CSE exposure compared to PBS‐instilled controls (Figure 1A). Even though total cell quantity
was also elevated in RAGE KO BALF, total BALF cells were significantly diminished in RAGE KO
mice exposed to CSE compared to CSE‐exposed wild type animals (Figure 1A). The percentage
of AMs in WT and RAGE KO BALF following acute CSE exposure trended downward, but was not
significantly different when compared to PBS‐exposed mice (Figure 1B). Lung sections from
RAGE KO and wild type animals were also immunostained for Mac‐3 24 hours after a single
exposure to PBS or CSE by nasal instillation. There was a detectable increase in Mac‐3 positive
cells in the wild type lung exposed to CSE (Figure 1D) compared to age‐matched wild type
littermates exposed to PBS vehicle only (Figure 1C). In addition, qualitative assessment of AMs
in CSE‐exposed RAGE KO mice by immunostaining (Figure 1E) revealed elevated Mac‐3 cells, but
most histological views appeared similar to wild type PBS‐exposed mice (Figure 1C). In order to
dissect RAGE‐mediated signaling in AMs, total BAL cells from wild type and RAGE KO mice were
harvested and cultured as outlined in Materials and Methods. So that a stable population of
AMs could be identified, immunohistochemistry was performed using a Mac‐3 antibody and
significant immunoreactivity was observed in adherent cells (Figure 1F, G).
In order to assess whether RAGE signaling was involved in primary AMs exposed to CSE,
we evaluated the degree to which RAGE was expressed at baseline and whether RAGE
expression increases following exposure to CSE. Through experiments involving quantitative
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RT‐PCR, we discovered that there was a significant increase in RAGE expression by primary AMs
isolated from wild type mice following CSE exposure compared to wild type AMs exposed to
fresh media (Figure 2). RAGE KO AMs were similarly evaluated and as anticipated, no RAGE
expression was detected in both the CSE or media exposed cell populations (Figure 2).
RAGE KO AMs have significantly diminished CSE‐induced Ras activation
Active Ras, an intracellular molecular switch involved in many signal transduction
pathways, was recently assessed in alveolar epithelium exposed to tobacco smoke (39). Our
research revealed RAGE‐mediated mechanisms of elevated Ras activity that precedes
inflammatory molecule elaboration in response to smoke exposure. In order to test the
hypothesis that Ras is also activated in primary AMs exposed to CSE, we exposed AMs isolated
from wild type and RAGE KO mice to 10% CSE over the course of 1, 2, and 4 hours. Using
techniques that immunologically assess active Ras, we discovered a significant increase of
active Ras expression in wild type primary AMs after only one hour of CSE exposure (Figure 3).
The data related to the time course revealed consistent increases in Ras activity as the duration
of CSE exposure progressed. Ras activity was also increased in primary AMs obtained from
RAGE KO mice; however, the amount of active Ras was consistently and significantly decreased
at each time point assessed (Figure 3).
RAGE KO AMs have significantly diminished CSE‐induced p38 MAPK and NF‐B activation
Because RAGE is elevated in AMs that encounter tobacco smoke and Ras, an important
cytosolic intermediate that perpetuates inflammation, is activated in part by RAGE, it was
important to dissect additional RAGE‐mediated signaling targets.

A series of experiments was

performed in order to analyze the activity of p38, an important mitogen‐activated protein
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kinase (MAPK) involved in inflammatory cell signaling (17).

Total p38 MAPK was not

significantly different when comparing AMs from RAGE KO or wild type mice (Figure 4A).
However, total p38 MAPK was decreased in both AM populations after 30 minutes of CSE
exposure (Figure 4A). Data revealed that CSE exposure for 30 minutes resulted in increased
phosphorylation and subsequent activation of p38 MAPK in both wild type and RAGE KO AMs
(Figure 4B). Importantly, p38 MAPK activation in RAGE KO AMs after 60 minutes of CSE
exposure was significantly diminished when compared to levels observed in CSE‐exposed wild
type AMs (Figure 4B).
We next assayed the state of NF‐B activation in cells exposed to CSE. As a downstream
target of Ras and MAPKs, including p38, NF‐B is phosphorylated and liberated from cytosolic
sequestration during an inflammatory response and it functions as a potent nuclear
transcription factor. Total NF‐B was not significantly different when comparing AMs from
RAGE KO and wild type mice (Figure 5A). Results revealed that the expression of active NF‐B
in CSE‐exposed RAGE KO AMs was significantly reduced when compared to CSE‐exposed AMs
from wild type controls (Figure 5B). Combined, these data suggest that CSE induces the
activation of p38 MAPK and NF‐B in AMs at least partially through RAGE signaling pathways.
CSE‐induced pro‐inflammatory cytokine secretion is diminished in RAGE KO AMs
In order to test the hypothesis that CSE‐induced RAGE expression leads to pro‐
inflammatory cytokine production, we analyzed the levels of TNF‐ and IL‐1 in AMs with and
without CSE exposure. Following exposure to CSE for two hours, quantitative RT‐PCR revealed
a significant increase in the expression of both cytokines by primary AMs from wild type mice
(Figure 6). Production of TNF‐ (Figure 6A) and IL‐1 (Figure 6B) mRNA was significantly
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decreased in primary AMs from RAGE KO mice exposed to CSE compared to CSE‐exposed AMs
from wild type controls. Although AMs from both wild type and RAGE KO mice increased
cytokine mRNA expression following CSE exposure, primary wild type AMs exposed to CSE had
significantly more cytokine expression when compared to CSE‐exposed RAGE KO AMs.
Differential expression of TNF‐ and IL‐1 after two hours of CSE exposure (Figure 6) was also
observed in experiments that involved four hours of CSE exposure (not shown). An assessment
of secreted cytokines after four hours revealed that IL‐1 production was similar to the mRNA
profile in that a significant decrease was observed in media obtained from CSE‐exposed KO AMs
compared to CSE‐exposed WT AMs (Table 1). Interestingly, acute TNF‐ secretion after four
hours was not different in any of the groups regardless of CSE exposure (Table 1).
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Discussion
AMs and tobacco smoke‐induced RAGE expression
Macrophages are dynamic cells capable of remarkably diverse gene expression patterns
following signal recognition of tissue‐specific events.

In particular, phagocytosis and

enhancement of the inflammatory response are defining macrophage characteristics in
programmed responses to acute and chronic pathological conditions (9). In fact, macrophages
are significant contributors to the organism’s immune system, with functions that include
phagocytic clearance of pathogens and other debris and service as a reservoir for a variety of
mediators that regulate inflammation, adaptive immunity, and homeostasis (25).

Such

modulators of inflammation and homeostasis are normally released to target invading
pathogens and enhance wound repair (24). However, regulatory mechanisms that control
inflammatory mediators can also become dysfunctional when external stimulation, including
exposure to tobacco smoke, persists.

Such chronic stimulation of macrophage‐mediated

immune responses may culminate in irreversible remodeling of resident tissues.
Originally characterized for its ability to bind AGEs, abundant data implicate RAGE as a
potent feed‐forward receptor involved in inflammation (46). AGEs arise in vivo from the non‐
enzymatic addition of reducing sugars to amino groups (30).

While AGEs such as

carboxymethyllsine (CML) are formed more abundantly at sites of inflammation in
hyperglycemic renal failure and in areas of localized oxidative stress (52), tobacco‐derived AGEs
formed via Malliard chemistry also provide abundant ligand for RAGE signaling (29).
Importantly, RAGE is a pattern recognition receptor, so there is a clear likelihood that diverse,
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yet related AGEs derived by a burning cigarette combine to induce pro‐inflammatory RAGE
signaling (5).
Our previous research demonstrated that exposure of pulmonary epithelial cells to CSE
led to increased expression of RAGE and its ligands, suggesting that epithelial cells respond
acutely to CSE by stimulating molecules required in the initial stages of RAGE signaling (38).
Importantly, RAW264.7 cells, a murine macrophage cell line, up‐regulated RAGE expression
following exposure to CSE (38). Despite these data, the literature was silent in terms of RAGE
biology in murine primary AMs that encounter tobacco smoke. Although not as robustly
characterized in macrophages, RAGE has been shown to be the receptor responsible for
HMGB1‐induced inflammation in rodent macrophages (22). Studies document that low levels
of RAGE are expressed by macrophages in normal conditions and that RAGE overexpression is
observed in macrophages that elicit inflammation and cause lung damage (28). Morbini et al.
confirmed the presence of AGEs in macrophages and observed AGE and RAGE are both
coexpressed by these immune cells (28). Our discovery that RAGE was markedly increased by
primary AMs exposed to tobacco smoke led to the hypothesis that RAGE signaling influences
acute responses by macrophages in smoke environs.
RAGE signaling during tobacco smoke exposure
Activation of RAGE is dependent upon a variety of ligands and RAGE/ligand interaction
leads to the activation of diverse signal transduction pathways, including Ras‐extracellular
signal regulated kinase 1/2 (ERK1/2), Cdc42/Rac, stress‐activated protein kinase/c‐Jun‐NH2‐
terminal kinase (SAPK/JNK) and p38 MAPK pathways (14). These signaling events can culminate
in the activation of transcription factors including NF‐B or CREB (20, 55).

Our lab has
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previously published data that proposes the likelihood of a positive feedback loop in which
ligand binding led to intracellular signaling that eventually enhanced additional RAGE
expression (38). Furthermore, RAGE in CSE‐exposed lung epithelial cells has been shown to
activate Ras in the initiation of smoke‐induced pro‐inflammatory signaling (39). Our data
detailing Ras activation in concert with increased RAGE availability links this important signaling
cascade in AMs with similar effects observed in pulmonary epithelial cells. Because anomalous
Ras expression has been implicated as a biomarker for COPD (26), our research suggests
plausible cooperation between pulmonary epithelial cells and resident macrophages in
advanced stages of inflammatory disease.
Our data further demonstrated that AMs exposed to CSE trigger an intracellular
signaling pathway mediated by MAPKs and NF‐B. Specifically, p38 MAPK activity peaked in
AMs from wild type mice after just 30 minutes of CSE exposure (Figure 4). While p38 MAPK
activation was also observed in RAGE KO AMs, there was a significant decrease in p38 MAPK
activity after 60 minutes of CSE exposure compared to wild type AMs (Figure 4). We also
demonstrated that after four hours, nuclear translocation of active NF‐B was significantly
diminished in smoke‐exposed RAGE KO AMs compared to smoke‐exposed AMs from control
mice (Figure 5). While RAGE signaling via p38 MAPK and NF‐B has recently been proposed in
diverse tissue types under various conditions (19, 41, 58), such signaling paradigms have not
been elucidated in AMs exposed to tobacco smoke.

Importantly, the signaling kinetics

presented in the current research are similar to those presented by Zhang et al. in that p38
MAPK activation peaked at 30 minutes and NF‐B activation peaked at four hours following
exposure of RAW234.7 to AGEs (57).
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RAGE‐mediated inflammatory cytokine secretion by AMs
The current investigation identified significant up‐regulation of TNF‐ and IL‐1, two
pro‐inflammatory cytokines related to COPD pathogenesis (6), by wild type AMs. A substantial
element of our research revealed that these important pro‐inflammatory effector molecules
were significantly decreased in CSE‐exposed AMs that lacked the capacity to express RAGE. The
current work is a natural extension of research by others that suggest an overall theme of
RAGE‐mediated responses to inflammatory insults including lipopolysaccharide (LPS),
Escherichia coli, or HMGB‐1 (22, 34, 47, 54). An intriguing discovery was that differential
cytokine expression by RAGE KO AMs as early as two hours after CSE exposure occurred.
Importantly, Wesselborg and colleagues outlined separate parallel pathways involving MAPK/
NF‐B in the orchestration of inflammation triggered by a variety of cellular stresses (51).
While our data demonstrate the plausibility of linear signaling that involves Ras, p38, and NF‐B
as intracellular intermediates, the modulation of inflammatory cytokines by RAGE after only
two hours of CSE exposure (Figure 6) suggests the likelihood of alternative parallel pathways.
Research by others confirmed that macrophage numbers are significantly increased in
the airways, parenchyma, BALF, and sputum of patients with COPD (1) and that activated
alveolar macrophages secrete various cytokines and chemokines following cigarette smoke
exposure (4). Additionally, specific analysis of peripheral blood monocytes from active smokers
further showed that enhanced NF‐B activation (49) coincided with altered levels of TNF‐, IL‐
1, IL‐6, and IL‐8 in BALF (27, 42). Primarily expressed by macrophages, TNF‐ stimulates the
release of diverse pro‐inflammatory and cytotoxic mediators including IL‐1, IL‐6, platelet
activating factor (PAF), eiconasoids, and reactive oxygen species (25). TNF‐ has been shown to
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regulate cellular proliferation (25) and the expression of ICAM‐1, an endothelial adhesion
molecule involved in leukocyte transmigration (23, 27). AM secretion of TNF‐ is increased in
experimental models of tissue injury (33) and when levels of TNF‐ increase, emphysematous
damage to lung parenchyma mediated by the release of matrix metalloproteinases (MMPs)
occurs (31, 48). IL‐1 is another potent cytokine released by macrophages known to stimulate
additional chemokine production, recruit leukocytes to sites of injury, and feedback to induce
elevated production of TNF‐ (17).

Like TNF‐, IL‐1 can also trigger MMP secretion,

particularly MMP‐9 (43), increase the proliferation of fibroblasts (10) and enhance collagen
synthesis (48). Sputum and lavage fluid from smokers have increased levels of IL‐1, and it is
proposed that high levels of IL‐1 are inversely related to pulmonary function (7). It is possible
that while additional mediators may lead to the amplification of inflammatory events
coordinated by TNF‐ and IL‐1, significantly diminished levels of these molecules in RAGE KO
AMs exposed to smoke reveal distinct RAGE‐mediated pathways.
Conclusions
The current study provides support for a model of smoke‐exposed AMs wherein RAGE‐
mediated signal transduction pathways influence inflammation. Therefore, our findings that
smoke increases RAGE expression, activates known intracellular pathways, and causes NF‐B‐
mediated cytokine elaboration have important implications for elucidating the mechanisms of
progressive lung inflammation experienced by both former smokers and those unable or
unwilling to quit. Clarifying RAGE signaling in the context of possible parallel pathways remains
an important consideration, however.

As such, additional research that centers on the
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important role of RAGE signaling and the resulting inflammatory response should remain a
priority.
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Figures and Tables
Figure 1

Figure 1

Bronchoalveolar lavage fluid was procured from RAGE KO and wild type mice

acutely exposed to CSE and assessed. Total BALF cells and the percentage of AMs were
significantly diminished in RAGE KO animals exposed to CSE compared to CSE‐exposed controls
(A, B). Twenty four hours after a single nasal instillation of PBS (C) or 10% CSE (D), wild type
mice stained for Mac‐3 revealed a marked increase in Mac‐3 positive AMs following CSE
exposure. RAGE KO mice were similarly administered 10% CSE and there was a detectible
decrease in the number of Mac‐3 positive AMs following qualitative immunohistochemical
assessment (E). BALF cells were procured, plated and immunostained with Mac‐3 in order to
identify a homogenous AM population.

All adherent cells expressed Mac‐3 (A) and

immunostaining in the absence of primary antibody revealed no immunoreactivity (B). BALF
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analyses were performed in triplicate and *p ≤ 0.05 (ANOVA). Representative images (400X
original magnification) of n = 3 mice in each group are shown.

Figure 2

Figure 2

Primary AMs from wild type or RAGE KO mice were plated overnight, exposed to

fresh media or 10% CSE for two hours, then screened by quantitative RT‐PCR. There was a
significant increase in the expression of RAGE by wild type AMs exposed to CSE and RAGE was
not detected in RAGE KO AMs with or without CSE exposure. RAGE transcripts were normalized
to GAPDH and representative data of experiments performed in triplicate are shown. *p ≤ 0.05
(Student’s t tests were conducted between both wild type groups and no tests were conducted
in KO samples due to failure to detect RAGE).
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Figure 3

Figure 3

Primary AMs from wild type or RAGE KO mice were plated overnight, exposed to

fresh media or 10% CSE for one, two, or four hours, then screened for active Ras. There was a
significant increase in active Ras after exposure of each AM population to 10% CSE.
Importantly, the quantity of active Ras was significantly decreased in RAGE KO AMs compared
to wild type AMs at each time point. Data are representative of experiments performed in
triplicate and *p ≤ 0.05 (ANOVA).
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Figure 4

Figure 4

Primary AMs from wild type or RAGE KO mice were plated overnight, exposed to

fresh media or 10% CSE for 30 or 60 minutes, then screened for total and active p38 MAPK.
Total p38 MAPK levels were not different between the two groups of cells at each time point,
although the total amount of p38 MAPK was diminished after 30 minutes of CSE exposure (A).
There was a significant increase in phosphorylated active p38 MAPK after exposure of each AM
population to 10% CSE for 30 minutes (B, p ≤ 0.05). Importantly, the quantity of active p38
MAPK was significantly decreased in RAGE KO AMs compared to wild type AMs at 60 minutes of
exposure. Data are representative of experiments performed in triplicate and *p ≤ 0.05
(ANOVA).
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Figure 5

Figure 5

Primary AMs from wild type or RAGE KO mice were plated overnight, exposed to

fresh media or 10% CSE for four hours, then screened for total and active p65 NF‐B. Total NF‐
B was not different in any of the AM populations (A). There was a significant increase in
phosphorylated active NF‐B after exposure of wild type AMs to CSE (B). Furthermore, RAGE
KO AMs exposed to CSE were not different from wild type AMs in the absence of CSE exposure.
Data are representative of experiments performed in triplicate and *p ≤ 0.05 (ANOVA).
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Figure 6

Figure 6

Primary AMs from wild type or RAGE KO mice were plated overnight, exposed to

fresh media or 10% CSE for two or four hours, then screened for cytokine mRNA expression.
Utilization of molecule‐specific quantitative RT‐PCR revealed that RAGE KO AMs exposed to CSE
expressed less TNF‐ and IL‐1 compared to wild type AMs exposed to CSE for two hours. The
pattern of differential cytokine mRNA expression was similar after four hours of exposure (not
shown). Data are representative of experiments performed in triplicate and *p ≤ 0.05 (ANOVA).
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Table 1

Table 1: Production of IL‐1 and TNF‐ by AMs +/‐ CSE exposure
WT AMs
WT AMs + CSE
KO AMs
KO AMs + CSE
28.9 ± 9.9
85.86 ± 9.3*
25.38 ± 4.3
61.44 ± 2.9*
IL‐1
215 ± 5.9
197 ± 19.2
226 ± 18.2
211 ± 21.2
TNF‐
Data are expressed as average pg/mL ± SD from at least two experiments
performed in triplicate. *Significant differences between no CSE vs. CSE
exposed WT or KO cells and significant differences between WT AMs + CSE vs.
KO AMs + CSE (p ≤ 0.05, AVOVA).
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CHAPTER 3:

DISCUSSION AND FUTURE DIRECTIONS

The conserved pro‐inflammatory contributions of RAGE have recently become subjects
of intense investigation due to their implication in numerous pathological states including
diabetes, atherosclerosis, rheumatological disorders, Alzheimer disease, and COPD (13, 26).
However, the involvement of explicit immune cells and the signaling events associated with
perpetuation of these debilitating diseases in the context of RAGE remains unclear. The current
study provides support for a model of smoke‐exposed AMs wherein RAGE‐mediated signal
transduction pathways influence inflammation. These findings revealed that smoke induced
AMs increased RAGE expression, activated known intracellular pathways such as Ras and p38
MAPK, and caused NF‐B‐mediated cytokine elaboration facilitated by RAGE mediated
mechanisms. These conclusions have important implications for elucidating the mechanisms of
progressive lung inflammation experienced by both former smokers and those unable or
unwilling to quit. Clarifying RAGE signaling in the context of possible parallel pathways remains
an important consideration, however.

As such, additional research that centers on the

important role of RAGE signaling and the resulting inflammatory response should remain a
priority.
Although the data presented here clarifies a linear RAGE‐mediated signal transduction
pathway activated by inflammation, further research may require investigating redundant cell
surface receptors that may also contribute to the overall inflammatory status of AMs following
CSE exposure. Current research has identified some of these contributing receptors including
IL‐17RA (4), VEGFR2 (6), IL‐1R (5), and Toll‐Like Receptors (TLRs) (29).

TLRs are pattern

recognition receptors closely associated with RAGE mediated mechanisms involved in

50
inflammation and may contribute to the increased cytokine production and activated signaling
intermediates seen following CSE exposure in macrophages (19, 29). These data show that
even when RAGE is abolished in knock out AMs, cytokine production and activated
intermediates still significantly increase, although the increase is significantly diminished when
compared to wild type controls. Further research is needed to explore the hypothesis that TLRs
in conjunction with RAGE may be responsible in initiating the inflammatory response following
CSE exposure in AMs.
While RAGE signaling via p38 MAPK and NF‐B has recently been proposed in diverse
tissue types under various conditions (9, 18, 30), such signaling paradigms have not been
elucidated in AMs exposed to tobacco smoke. The data in the current thesis demonstrate that
p38 and NF‐B activation occur, in part, through RAGE signaling. The data presented herein
also support signaling kinetics published by Zhang et al. in that p38 MAPK activation peaked at
30 minutes and NF‐B activation peaked at four hours following exposure of RAW264.7 to AGEs
(28). However, whether p38 and NF‐B activation occur in a sequential signaling pattern
remains unclear. Additionally, downstream signaling intermediates require analysis such as Src
kinase, which is implicated as perpetuating the intracellular signal following RAGE activation,
leading to activation of MAPKs such as p38, ERK1/2, and transcription factors such as NF‐B
(15).
Macrophages are dynamic cells capable of remarkably diverse gene expression patterns,
as well as abundant secretion of inflammatory mediators, following signal recognition of tissue‐
specific events. Although macrophages are well known for their phagocytic activity, lung
macrophages develop the capacity to release large quantities of mediators that regulate
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inflammation and homeostasis including cytokines, growth factors, oxidants, and enzymes (11).
The data presented in the current work indicate that AMs up regulate pro‐inflammatory
cytokines TNF‐ and IL‐1 via RAGE after CSE exposure, but does not evaluate the entire gamut
of AM secretory products.

MMPs, matrix metalloproteinases, are enzymes secreted by

macrophages that may contribute to perpetuating inflammation and induce lung remodeling as
seen in patients with COPD. In particular, MMP‐12 is increased in patients with COPD (12), and
MMP‐9 is implicated in causing cigarette smoke‐induced emphysema (1). Work by our lab has
shown that RAGE over expression in alveolar epithelium leads to increased MMP‐9 activity and
results in destabilization of the basement membrane.

Additional studies are needed to

complete a thorough examination of MMP and cytokine secretion activity by AMs and
determine whether RAGE mediates their activities.
HMGB1, high mobility group box 1, has a high affinity for binding RAGE and is released
by damaged or necrotic cells, and by immune cells such as macrophages (7, 10). Kokkola et al
found that HMGB1 induces a pro‐inflammatory phenotype through RAGE in rodent
macrophages (10) and previous work in our lab has shown that RAW264.7, a macrophage cell
line, exposed to CSE increases HMGB1 expression, in addition to various cytokines (16).
HMGB1 has also been shown to induce macrophage production of TNF‐ (20)and IL‐1 (14) as
well as chemotactic and cytotoxic factors (22). In patients with COPD, HMGB1 expression is
increased, and it is suggested that binding of HMGB1 to RAGE amplifies the inflammatory and
remodeling signals that contribute to COPD pathogenesis (7). The data presented in the
current research lays the groundwork for additional studies because of the suggestion that
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RAGE signaling triggers pro‐inflammatory effects in AMs following exposure to CSE, but further
work exploring the interactions HMGB1 and RAGE due to CSE exposure may prove beneficial.
Hogg et al states that a more complete understanding of the cytokine pathways that
control disease progression may lead to effective treatments and mechanisms wherein
therapies can improve (8). The data currently presented indicate that AMs up regulate pro‐
inflammatory cytokines TNF‐ and IL‐1 via RAGE after CSE exposure. Several other cytokines
in the current literature such as IL‐8 (3, 27), TGF‐1 (29), IL‐6 (25), and MCP‐1 and MIP (24)
increased following cigarette smoke exposure in macrophages. In addition, cigarette smoke
induced oxidative stress due to components in tobacco smoke or reactive oxygen species
generated by macrophages may potentiate the inflammatory and irreversible remodeling
process in the lung (19, 21). Since RAGE has been shown to be involved in propagating
oxidative stress mechanisms leading to inflammation, studying the participation of RAGE in
AM’s ability to generate and produce oxidants will be critical in understanding RAGE
contributions (2, 17).
The current study provides support for a model of smoke‐exposed AMs wherein RAGE‐
mediated signal transduction pathways influence inflammation. This research provides the
basis for possible therapeutic strategies that could be formulated for the prevention of smoke‐
induced pro‐inflammatory effects. Furthermore, therapeutic intervention may assist in the
alleviation of lung disease exacerbations in individuals with respiratory susceptibilities to a host
of other particulates as well. Finally, the data presented here not only clarify RAGE biology in
the context of smoke‐exposed alveolar macrophages, but also provide evidence suggesting
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involvement of inadequately characterized redundant receptors and signaling pathways that
function in tobacco smoke‐induced pulmonary inflammation.

54
References
1.

Atkinson JJ, Lutey BA, Suzuki Y, Toennies HM, Kelley DG, Kobayashi DK, Ijem WG,

Deslee G, Moore CH, Jacobs ME, Conradi SH, Gierada DS, Pierce RA, Betsuyaku T, and Senior
RM. The role of matrix metalloproteinase‐9 in cigarette smoke‐induced emphysema. Am J
Respir Crit Care Med 183: 876‐884, 2011.
2.

Bansal S, Siddarth M, Chawla D, Banerjee BD, Madhu SV, and Tripathi AK. Advanced

glycation end products enhance reactive oxygen and nitrogen species generation in neutrophils
in vitro. Mol Cell Biochem 361: 289‐296, 2012.
3.

Birrell MA, Wong S, Catley MC, and Belvisi MG. Impact of tobacco‐smoke on key

signaling pathways in the innate immune response in lung macrophages. J Cell Physiol 214: 27‐
37, 2008.
4.

Chen K, Pociask DA, McAleer JP, Chan YR, Alcorn JF, Kreindler JL, Keyser MR, Shapiro

SD, Houghton AM, Kolls JK, and Zheng M. IL‐17RA is required for CCL2 expression, macrophage
recruitment, and emphysema in response to cigarette smoke. PLoS ONE 6: e20333, 2011.
5.

Churg A, Zhou S, Wang X, Wang R, and Wright JL. The Role of Interleukin‐1B in Murine

Cigarette Smoke‐Induced Emphysema and Small Airway Remodeling. Am J Respir Cell Mol Biol
40: 482‐490, 2009.
6.

Edirisinghe I, and Rahman I. Cigarette smoke‐mediated oxidative stress, shear stress,

and endothelial dysfunction: role of VEGFR2. Ann N Y Acad Sci 1203: 66‐72, 2010.
7.

Ferhani N, Letuve S, Kozhich A, Thibaudeau O, Grandsaigne M, Maret M, Dombret MC,

Sims GP, Kolbeck R, Coyle AJ, Aubier M, and Pretolani M. Expression of high‐mobility group

55
box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary
disease. Am J Respir Crit Care Med 181: 917‐927, 2010.
8.

Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers

RM, Sciurba FC, Coxson HO, and Pare PD. The nature of small‐airway obstruction in chronic
obstructive pulmonary disease. N Engl J Med 350: 2645‐2653, 2004.
9.

Hu P, Lai D, Lu P, Gao J, and He H. ERK and Akt signaling pathways are involved in

advanced glycation end product‐induced autophagy in rat vascular smooth muscle cells.
International journal of molecular medicine 29: 613‐618, 2012.
10.

Kokkola R, Andersson A, Mullins G, Ostberg T, Treutiger CJ, Arnold B, Nawroth P,

Andersson U, Harris RA, and Harris HE. RAGE is the major receptor for the proinflammatory
activity of HMGB1 in rodent macrophages. Scand J Immunol 61: 1‐9, 2005.
11.

Laskin DL. Macrophages and inflammatory mediators in chemical toxicity: a battle of

forces. Chemical research in toxicology 22: 1376‐1385, 2009.
12.

Molet S, Belleguic C, Lena H, Germain N, Bertrand CP, Shapiro SD, Planquois JM,

Delaval P, and Lagente V. Increase in macrophage elastase (MMP‐12) in lungs from patients
with chronic obstructive pulmonary disease. Inflammation research : official journal of the
European Histamine Research Society [et al] 54: 31‐36, 2005.
13.

Morbini P, Villa C, Campo I, Zorzetto M, Inghilleri S, and Luisetti M. The receptor for

advanced glycation end products and its ligands: a new inflammatory pathway in lung disease?
Mod Pathol 19: 1437‐1445, 2006.
14.

Mouri F, Tsukada J, Mizobe T, Higashi T, Yoshida Y, Minami Y, Izumi H, Kominato Y,

Kohno K, and Tanaka Y. Intracellular HMGB1 transactivates the human IL1B gene promoter

56
through association with an Ets transcription factor PU.1. European journal of haematology 80:
10‐19, 2008.
15.

Reddy MA, Li SL, Sahar S, Kim YS, Xu ZG, Lanting L, and Natarajan R. Key role of Src

kinase in S100B‐induced activation of the receptor for advanced glycation end products in
vascular smooth muscle cells. J Biol Chem 281: 13685‐13693, 2006.
16.

Reynolds PR, Kasteler SD, Cosio MG, Sturrock A, Huecksteadt T, and Hoidal JR. RAGE:

developmental expression and positive feedback regulation by Egr‐1 during cigarette smoke
exposure in pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 294: L1094‐1101,
2008.
17.

Reynolds PR, Schmitt RE, Kasteler SD, Sturrock A, Sanders K, Bierhaus A, Nawroth PP,

Paine R, 3rd, and Hoidal JR. Receptors for advanced glycation end‐products targeting protect
against hyperoxia‐induced lung injury in mice. Am J Respir Cell Mol Biol 42: 545‐551, 2010.
18.

Riuzzi F, Sorci G, Sagheddu R, and Donato R. HMGB1/RAGE regulates muscle satellite

cell homeostasis via p38 MAPK/myogenin‐dependent repression of Pax7 transcription. Journal
of Cell Science 2012.
19.

Sarir H, Mortaz E, Karimi K, Kraneveld AD, Rahman I, Caldenhoven E, Nijkamp FP, and

Folkerts G. Cigarette smoke regulates the expression of TLR4 and IL‐8 production by human
macrophages. J Inflamm (Lond) 6: 12, 2009.
20.

Scaffidi P, Misteli T, and Bianchi ME. Release of chromatin protein HMGB1 by necrotic

cells triggers inflammation. Nature 418: 191‐195, 2002.
21.

Seagrave J. Oxidative mechanisms in tobacco smoke‐induced emphysema. J Toxicol

Environ Health A 61: 69‐78, 2000.

57
22.

Sims GP, Rowe DC, Rietdijk ST, Herbst R, and Coyle AJ. HMGB1 and RAGE in

inflammation and cancer. Annu Rev Immunol 28: 367‐388, 2010.
23.

Stogsdill JA, Stogsdill MP, Porter JL, Hancock JM, Robinson AB, and Reynolds PR.

Embryonic over‐expression of RAGE by alveolar epithelium induces an imbalance between
proliferation and apoptosis. Am J Respir Cell Mol Biol 2012.
24.

van der Vaart H, Postma DS, Timens W, and ten Hacken NH. Acute effects of cigarette

smoke on inflammation and oxidative stress: a review. Thorax 59: 713‐721, 2004.
25.

Vecchio D, Arezzini B, Pecorelli A, Valacchi G, Martorana PA, and Gardi C. Reactivity of

mouse alveolar macrophages to cigarette smoke is strain dependent. Am J Physiol Lung Cell Mol
Physiol 298: L704‐713, 2010.
26.

Wu L, Ma L, Nicholson LF, and Black PN. Advanced glycation end products and its

receptor (RAGE) are increased in patients with COPD. Respir Med 105: 329‐336, 2011.
27.

Yang SR, Chida AS, Bauter MR, Shafiq N, Seweryniak K, Maggirwar SB, Kilty I, and

Rahman I. Cigarette smoke induces proinflammatory cytokine release by activation of NF‐
kappaB and posttranslational modifications of histone deacetylase in macrophages. Am J
Physiol Lung Cell Mol Physiol 291: L46‐57, 2006.
28.

Zhang F, Banker G, Liu X, Suwanabol PA, Lengfeld J, Yamanouchi D, Kent KC, and Liu B.

The Novel Function of Advanced Glycation End Products in Regulation of MMP‐9 Production. J
Surg Res 2010.
29.

Zhou J, Eksioglu EA, Fortenbery NR, Chen X, Wang H, Epling‐Burnette PK, Djeu JY, and

Wei S. Bone Marrow Mononuclear Cells Up‐Regulate Toll‐Like Receptor Expression and Produce
Inflammatory Mediators in Response to Cigarette Smoke Extract. PLoS ONE 6: e21173, 2011.

58
30.

Zhu P, Ren M, Yang C, Hu YX, Ran JM, and Yan L. Involvement of RAGE, MAPK and NF‐

kappaB pathways in AGEs‐induced MMP‐9 activation in HaCaT keratinocytes. Experimental
dermatology 21: 123‐129, 2012.

59
CURRICULUM VITAE

NAME:

Adam B. Robinson

ADDRESS:

665 Wymount Terrace
Provo, UT 84604
(801) 361‐5829
adambnr@gmail.com

EDUCATION:

B.S., Physiology and Developmental Biology (April 2011)
Brigham Young University, Dept. of Physiology and Developmental Biol.
Provo, UT 84602
M.S., Physiology and Developmental Biology (Expected August 2012)
Brigham Young University, Dept. of Physiology and Developmental Biol.
Provo, UT 84602
Thesis: The Pro‐Inflammatory Contributions of Receptors for Advanced
Glycation End‐Products (RAGE) in Alveolar Macrophages Following
Cigarette Smoke Exposure
Advisor: Dr. Paul R. Reynolds

PROFESSIONAL EXPERIENCE:
Research Assistant And Undergraduate Mentor (Sept 2009‐present)
Brigham Young University, Dept. of Physiology and Developmental Biol.
Provo, UT 84602
Supervisor: Dr. Paul R. Reynolds
375A WIDB
(801) 422‐1933
paul_reynolds@byu.edu
Duties:
 Design and perform research projects centered on RAGE
biology during cigarette smoke exposure.
 Manage data, analysis, and literature reviews.
 Provide meaningful presentations of scientific work.
 Operate and maintain diverse laboratory equipment.
 Train, mentor and assist undergraduates in laboratory
techniques and ensure proficiency.
Teaching Assistant & Laboratory Instructor (Jan 2009‐April 2012)
Brigham Young University, Departments of Physiology and
Developmental Biology and Microbiology and Molecular Biology.

60
Molecular and Microbiology Lab (MMBio 241); Jan 2009 – June 2011
Human Embryology (PDBio 484); Aug 2011 – Dec 2011
Physiology Lab (PDBio 305); Jan 2012 – April 2012.
Duties:
 Teach, mentor, and maintain a class of undergraduate students
weekly.
 Train and mentor peer instructors and teaching assistants.
 Grade all exams and written assignments.
 Prepare, organize, and troubleshoot all laboratory reagents
and materials.
SERVICE AND OUTREACH:

Hospice Volunteer
 Visited and attended to an elderly couple weekly in order to
provide support, care, and attention.
LABORATORY SKILLS:
Lab Equipment
 Spectrophotometer, thermal cycler, light microscope, centrifuge,
incubator/water bath, vacuum.
Cell Culture
 Obtaining and maintaining primary murine alveolar macrophages
 Maintaining immortalized cell lines
Molecular Laboratory Techniques
 DNA Extraction: DNA extraction of animal (mouse) tissue
 RNA Extraction: Qiagen RNeasy protocol using primary cells
 Gene Amplification: Standard PCR, cDNA amplification with
Reverse Transcriptase, Real Time PCR analysis, gel
electrophoresis.
 Protein Analysis: Protein isolation from tissue and cells using
RIPA/inhibitor cocktail, Western blotting, ELISA, FACE (Fast
Activated Cell Based ELISA)
PUBLICATIONS:
Peer reviewed manuscripts
Stogsdill JA, Stogsdill MP, Porter JL, Hancock JM, Robinson AB, Reynolds
PR. (2012). Embryonic over‐expression of RAGE by alveolar epithelium
induces an imbalance between proliferation and apoptosis. American
Journal of Respiratory Cell and Molecular Biology, EPub Feb 16, 2012.
Robinson AB, Johnson KD, Bennion BG, Reynolds PR. (2012). RAGE
signaling by pulmonary macrophages influences tobacco smoke‐induced

61
inflammation. American journal of physiology. Lung cellular and
molecular physiology 302, L1192‐1199.
Submitted manuscripts
Robinson AB, Stogsdill JA, Lewis JP, Wood TA, and Reynolds PR. RAGE
biology and Second hand smoke: Insights in Chronic Obstructive
Pulmonary Disease. In preparation.
ABSTRACTS:
Robinson AB, Johnson KD, Bennion BG, and Reynolds PR (2012). RAGE
signaling influences tobacco smoke‐induced inflammation by pulmonary
macrophages. FASEB.
Johnson KD, Robinson AB, and Reynolds PR (2012). RAGE signaling
contributes to pro‐inflammatory cytokine secretion by tobacco smoke‐
exposed primary alveolar macrophages. FASEB.
Geyer AJ, Ferguson NT, Stogsdill JA, Robinson AB, and Reynolds PR
(2011). Conditional embryonic over‐expression of RAGE in the mouse
lung diminishes pulmonary endothelium expression. Developmental
Biology 356, 143‐143.
AWARDS AND RECOGNITIONS
BYU Teaching Assistantships: 2
BYU Research Assistantships: 2
Spring 2012 Research Presentation Award. BYU Graduate Student Society
Spring 2012 American Physiological Society (APS) Travel Award
Winter 2012 BYU Dept. of Physiology and Developmental Biol.
Scholarship
Fall 2011 BYU Dept. of Physiology and Developmental Biol. Scholarship
MEMBERSHIP IN PROFESSIONAL ORGANIZATIONS:
American Association for the Advancement of Science (AAAS)
American Physiology Society (APS)
REFERENCES:
Dr. Paul R. Reynolds, Ph.D.
Department of Physiology and Developmental Biology
Brigham Young University, 375A WIDB
Provo, UT 84602
(801) 422‐1933
paul_reynolds@byu.edu

62
Dr. Sterling N. Sudweeks, Ph.D.
Department of Physiology and Developmental Biology
Brigham Young University, 595 WIDB
Provo, UT 84602
(801) 422‐8752
sterling_sudweeks@byu.edu
Dr. Brian D. Poole, Ph.D.
Department of Microbiology and Molecular Biology
Brigham Young University
Provo, UT 84602
(801) 422‐8092
bpoole@gmail.com
Dr. Adam Rupper, Ph.D.
Department of Microbiology and Molecular Biology
Brigham Young University, 450 MARB
Provo, UT 84602
arupper@gmail.com

